2 Millionaire-Maker AI Stocks to Hold for the Next Decade

The article is highly constructive on Credo Technology and Marvell Technology, framing both as critical AI infrastructure beneficiaries with durable demand tailwinds. Credo's AI networking cables are highlighted as increasingly indispensable, with Microsoft, Amazon, and xAI as customers and CEO compensation tied to revenue milestones of $2.5B to $7.5B by 2031. Marvell is boosted by Nvidia's reported $2 billion investment and integration into NVLink Fusion, while its custom silicon pipeline is said to include 18 XPU/XPU-attach sockets and more than 50 opportunities tied to $75 billion in lifetime revenue potential.

Analysis

The market is still treating AI as a single-stock narrative, but the more durable economic rent is shifting to bottleneck components with switching costs and qualification inertia. That favors the names that sit one layer below the compute headline: the interconnect and rack-level plumbing where scaling pain becomes visible only after hyperscaler capex has already been committed. In that setup, MRVL is the cleaner second-order beneficiary because it participates in both the custom-silicon substitution story and the need to remain compatible with Nvidia’s ecosystem, which lowers the odds that custom chips fully disintermediate the incumbent platform.

CRDO is the more asymmetric but also more fragile expression. The key hidden variable is not unit growth but design-win breadth across hyperscalers and optical partners, which can create a multi-quarter revenue step-function once deployments cross a critical density threshold. That said, the name is vulnerable to architecture resets: if a large buyer standardizes on an internal alternative or moves faster toward optical/SerDes solutions that bypass AECs, the multiple can compress quickly because the market is already pricing in a long runway.

The consensus may be underestimating how much MRVL benefits from being the “picks and shovels for both camps.” Even if hyperscalers keep diversifying away from Nvidia GPUs, that does not necessarily hurt MRVL; it can increase attach rates if every custom accelerator still needs rack-scale compatibility and interconnect support. The contrarian risk is that the upside here is less about TAM and more about timing: these stocks can rerate ahead of revenue inflection, then go flat for 2-3 quarters while investors wait for the next disclosed customer ramp.

From a portfolio perspective, the better trade is to own the infrastructure enablers that sit on both sides of the AI architecture debate and fade any attempt to short Nvidia as a proxy for that thesis. The likely losers are generic networking and cable suppliers without proprietary qualification or hyperscaler-specific design wins, because once these deployments are standardized, procurement tends to consolidate around the few vendors that already passed reliability and power-efficiency hurdles.

Key Decisions for Investors

• Long MRVL on pullbacks over the next 2-6 weeks; target a 12-18 month hold. Risk/reward is favorable because the stock can compound on both custom-chip wins and Nvidia ecosystem attach, while downside is limited by its role as an infrastructure enabler rather than a pure architecture bet.
• Use CRDO as a tactical momentum long only on weakness, not strength, over the next 1-3 months. Prefer staggered entries because customer concentration can create sharp drawdowns if a hyperscaler delays a ramp; upside remains strong if the next 1-2 quarters confirm broader deployment breadth.
• Pair trade: long MRVL / short a basket of higher-beta AI semiconductor names with less direct infrastructure exposure over 3-6 months. The trade expresses the view that infrastructure content per AI dollar spent is expanding faster than compute beta alone.
• Avoid shorting NVDA as a way to express skepticism on custom silicon. The more likely outcome over the next 6-12 months is ecosystem expansion, not displacement; custom chips can still increase total Nvidia-adjacent content per rack.
• For aggressive accounts, buy 6-12 month call spreads in MRVL rather than outright equity. This captures rerating from ecosystem leverage while defining risk if the market over-discusses the story before revenue converts.